Literature DB >> 30498701

Is the Surgical Margin in Gastrointestinal Stromal Tumors Different?

Piotr Rutkowski1, Jacek Skoczylas2, Piotr Wisniewski1.   

Abstract

BACKGROUND: Radical surgical excision is the mainstay of therapy of primary, nonmetastatic gastrointestinal stromal tumors (GIST) and margin status after surgery is a significant prognostic factor. METHODS AND
RESULTS: The aim of this paper is to review principles in primary GIST surgery, i.e. differences between R0, R1, and R2 resection, to describe how surgical margin status and tumor intraperitoneal rupture influence the patients' outcome, and how this may be effected by neoadjuvant and adjuvant treatment in locally advanced tumors. A systematic search of literature published between 2000 and 2018 was performed regarding this topic.
CONCLUSION: Correct interpretation of margin status after surgery can be affected by many factors during operation and preparation of tissue.

Entities:  

Keywords:  Gastrointestinal stromal tumor; Imatinib; Margin; Neodjuvant; Pathology; Surgery; Tumor perforation

Year:  2018        PMID: 30498701      PMCID: PMC6257087          DOI: 10.1159/000491649

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  44 in total

1.  Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract.

Authors:  Moon Kyung Joo; Jong-Jae Park; Ho Kim; Jin Sung Koh; Beom Jae Lee; Hoon Jai Chun; Sang Woo Lee; You-Jin Jang; Young-Jae Mok; Young-Tae Bak
Journal:  Gastrointest Endosc       Date:  2015-07-31       Impact factor: 9.427

2.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

4.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

5.  Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

Authors:  J A Crosby; C N Catton; A Davis; J Couture; B O'Sullivan; R Kandel; C J Swallow
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

6.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

Authors:  J P Pierie; U Choudry; A Muzikansky; B Y Yeap; W W Souba; M J Ott
Journal:  Arch Surg       Date:  2001-04

7.  Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection.

Authors:  Junichi Nishimura; Kiyokazu Nakajima; Takeshi Omori; Tsuyoshi Takahashi; Akiko Nishitani; Toshinori Ito; Toshirou Nishida
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 4.584

8.  Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.

Authors:  Piotr Rutkowski; Alessandro Gronchi; Peter Hohenberger; Sylvie Bonvalot; Patrick Schöffski; Sebastian Bauer; Elena Fumagalli; Pawel Nyckowski; Buu-Phuc Nguyen; Jan Martijn Kerst; Marco Fiore; Elzbieta Bylina; Mathias Hoiczyk; Annemieke Cats; Paolo G Casali; Axel Le Cesne; Jürgen Treckmann; Eberhard Stoeckle; Johannes H W de Wilt; Stefan Sleijfer; Ronald Tielen; Winette van der Graaf; Cornelis Verhoef; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2013-06-13       Impact factor: 5.344

9.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

Authors:  Heikki Joensuu
Journal:  Hum Pathol       Date:  2008-10       Impact factor: 3.466

10.  Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.

Authors:  R Tielen; C Verhoef; F van Coevorden; H Gelderblom; S Sleijfer; H H Hartgrink; J J Bonenkamp; W T A van der Graaf; J H W de Wilt
Journal:  Eur J Surg Oncol       Date:  2012-10-16       Impact factor: 4.424

View more
  4 in total

Review 1.  Lap-Endo cooperative surgery (LECS) in gastric GIST: updates and future advances.

Authors:  Thomas Zheng Jie Teng; Farhan Ishraq; Amelia Fang Ting Chay; Kon Voi Tay
Journal:  Surg Endosc       Date:  2022-10-11       Impact factor: 3.453

2.  Outcomes of Local Excision Compared to Radical Excision of Rectal Gastrointestinal Stromal Tumors: A Propensity-Score Matched Analysis of the NCDB.

Authors:  Sameh Hany Emile; Nir Horesh; Michael R Freund; Zoe Garoufalia; Rachel Gefen; Emanuela Silva-Alvarenga; Steven D Wexner
Journal:  World J Surg       Date:  2022-10-11       Impact factor: 3.282

3.  Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy.

Authors:  Nikolaos Vassos; Jens Jakob; Georg Kähler; Peter Reichardt; Alexander Marx; Antonia Dimitrakopoulou-Strauss; Nils Rathmann; Eva Wardelmann; Peter Hohenberger
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  On the Track of New Endoscopic Alternatives for the Treatment of Selected Gastric GISTs-A Pilot Study.

Authors:  Artur Raiter; Katarzyna M Pawlak; Katarzyna Kozłowska-Petriczko; Jan Petriczko; Joanna Szełemej; Anna Wiechowska-Kozłowska
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.